A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis

BackgroundStage IV colorectal cancer patients with unresectable metastasis who undergo elective primary tumour resection experience heterogeneous post-operative survival. We aimed to develop a scoring model for predicting post-operative survival using pre-operative variables to identify patients who are least likely to experience extended survival following the procedure.MethodsSurvival data were collected from stage IV colorectal cancer patients who had undergone elective primary tumour resection between January 1999 and December 2007. Coefficients of significant covariates from the multivariate Cox regression model were used to compute individual survival scores to classify patients into three prognostic groups. A survival function was derived for each group via Kaplan-Meier estimation. Internal validation was performed.ResultsAdvanced age (hazard ratio, HR 1.43 (1.16–1.78)); poorly differentiated tumour (HR 2.72 (1.49–5.04)); metastasis to liver (HR 1.76 (1.33–2.33)), lung (HR 1.37 (1.10–1.71)) and bone (HR 2.08 ((1.16–3.71)); carcinomatosis (HR 1.68 (1.30–2.16)); hypoalbuminaemia (HR 1.30 (1.04–1.61) and elevated carcinoembryonic antigen levels (HR 1.89 (1.49–2.39)) significantly shorten post-operative survival. The scoring model separated patients into three prognostic groups with distinct median survival lengths of 4.8, 12.4 and 18.6 months (p < 0.0001). Internal validation revealed a concordance probability estimate of 0.65 and a time-dependent area under receiver operating curve of 0.75 at 6 months. Temporal split-sample validation implied good local generalizability to future patient populations (p < 0.0001).ConclusionPredicting survival following elective primary tumour resection using pre-operative variables has been demonstrated with the scoring model developed. Model-based survival prognostication can support clinical decisions on elective primary tumour resection eligibility.

[1]  K. Sugihara,et al.  Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate? , 2013, International Journal of Clinical Oncology.

[2]  J. Church,et al.  Operation in patients with incurable colon cancer—Is it worthwhile? , 1997, Diseases of the colon and rectum.

[3]  B. Nordlinger,et al.  Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases , 2005, The British journal of surgery.

[4]  A. Jemal,et al.  Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[5]  W. Law,et al.  Outcomes of resection of stage IV rectal cancer with mesorectal excision , 2006, Journal of surgical oncology.

[6]  A. Ardizzoni,et al.  Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it? , 2011, Surgery Today.

[7]  N. Kim,et al.  Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis , 2014, Journal of surgical oncology.

[8]  S. Barni,et al.  Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  W. Sauerbrei,et al.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.

[10]  J. Kim,et al.  Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis , 2014, Journal of surgical oncology.

[11]  Douglas G Altman,et al.  Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.

[12]  R. McLeod,et al.  Liver resection for colorectal cancer metastases. , 2013, Current oncology.

[13]  R. Costi,et al.  TOPIC HIGHLIGHT , 2014 .

[14]  Rebecca L. Siegel Mph,et al.  Colorectal cancer statistics, 2014 , 2014 .

[15]  Y. Kim,et al.  The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer , 2013, Annals of coloproctology.

[16]  M. Kairaluoma,et al.  Palliative operations for colorectal cancer , 1990, Diseases of the colon and rectum.

[17]  A. Jemal,et al.  Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States , 2014, Cancer Causes & Control.

[18]  D. Ionescu,et al.  Pre-operative hypoalbuminemia in colorectal cancer patients undergoing elective surgery - a major risk factor for postoperative outcome. , 2013, Chirurgia.

[19]  C. Boselli,et al.  Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. , 2012, The Cochrane database of systematic reviews.

[20]  M. Scotté,et al.  Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? , 2004, Gastroenterologie clinique et biologique.

[21]  J. Huh,et al.  The Role of Palliative Resection for Asymptomatic Primary Tumor in Patients With Unresectable Stage IV Colorectal Cancer , 2014, Diseases of the colon and rectum.

[22]  R. Single,et al.  Surgical Resection of Primary Tumors in Patients Who Present With Stage IV Colorectal Cancer: An Analysis of Surveillance, Epidemiology, and End Results Data, 1988 to 2000 , 2005, Annals of Surgical Oncology.

[23]  Matthias Schmid,et al.  A comparison of estimators to evaluate the discriminatory power of time‐to‐event models , 2012, Statistics in medicine.

[24]  Thomas A Gerds,et al.  Estimating a time‐dependent concordance index for survival prediction models with covariate dependent censoring , 2013, Statistics in medicine.

[25]  M. Gonen,et al.  Concordance probability and discriminatory power in proportional hazards regression , 2005 .

[26]  J. Guillem,et al.  Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. , 2003, Journal of the American College of Surgeons.

[27]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[28]  A. Ulrich,et al.  Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis. , 2015, Annals of surgery.

[29]  C. Tang,et al.  Stage IV Colorectal Cancers: An Analysis of Factors Predicting Outcome and Survival in 728 cases , 2012, Journal of Gastrointestinal Surgery.

[30]  S. H. Cheng,et al.  How aggressive should we be in patients with stage iv colorectal cancer? , 2003, Diseases of the colon and rectum.

[31]  Guh Jung Seo,et al.  Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer , 2010, Journal of surgical oncology.

[32]  M. Koch,et al.  Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS - a randomised controlled multicentre trial (ISRCTN30964555) , 2012, BMC Cancer.

[33]  R. Berger,et al.  Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location , 2013, Cancer.